Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0OR5S
|
|||
Former ID |
DNC006064
|
|||
Drug Name |
2-(Benzylamino)-6-(3-acetamidophenyl)pyrazine
|
|||
Synonyms |
CHEMBL199800; 2-(Benzylamino)-6-(3-acetamidophenyl)pyrazine
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C19H18N4O
|
|||
Canonical SMILES |
CC(=O)NC1=CC=CC(=C1)C2=CN=CC(=N2)NCC3=CC=CC=C3
|
|||
InChI |
1S/C19H18N4O/c1-14(24)22-17-9-5-8-16(10-17)18-12-20-13-19(23-18)21-11-15-6-3-2-4-7-15/h2-10,12-13H,11H2,1H3,(H,21,23)(H,22,24)
|
|||
InChIKey |
APNYMHFAZCCZRG-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Novel inhibitors of B-RAF based on a disubstituted pyrazine scaffold. Generation of a nanomolar lead. J Med Chem. 2006 Jan 12;49(1):407-16. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.